Prof. Marco Metra
Session number: 902
Session title: The European Heart Journal’s / European Journal of Heart Failure’s year in Cardiology
Authors: Marco Metra (Brescia, Italy)
This session was aimed at showing the most significant articles published in the last year in the European Heart Journal and European Journal of Heart Failure. Prof Thomas Luescher introduced the topic, showing the family of European Society of Cardiology (ESC) affiliated journals, now also including the European Heart Journal: Cardiovascular Pharmacotherapy, the European Heart Journal: Quality of Care and Clinical Outcomes, and the open access journal ESC Heart Failure. He also showed the rapidly increasing impact factor of the European Heart Journal (EHJ), bringing it to the top level among cardiology journals, as well as the improvement of all the affiliated journals, with the European Journal of Heart Failure ranking first among heart failure (HF) journals.
Fausto Pinto summarized the main progress in cardiovascular imaging for HF, including the application of techniques to detect more subtle abnormalities of left ventricular (LV) function such as LV global longitudinal strain, speckle-tracking strain analysis, cardiac magnetic resonance imaging with late gadolinium enhancement and stress test to assess LV diastolic function.
Piotr Ponikowski showed the recently published epidemiological data regarding HF in France, namely the CardShock study, analyzing the prognostic value of the response to diuretic therapy in acute HF. The recently issued recommendations about the management of acute HF were also highlighted.
Data regarding the clinical and prognostic significance of iron deficiency and the beneficial effects of iron therapy with ferric carboxymaltose were shown by both Prof. Ponikowski and Prof. John McMurray. John McMurray also presented data regarding the effects of LCZ696 administration in patients with HF, as well as a review of the development of this new compound. Disease management programs were also analyzed.
Lastly, Kenneth Dickstein focused on devices in HF treatment, considering the interatrial septal device for HF with high intra-atrial pressure, the mitra-clip system for mitral regurgitation, PARACHUTE implantation for LV aneurysm, chronic baroreflex activation, pump speed modulation of LV assist device (LVAD), and the effects of LVAD on diabetic control. To finish, the effects of cardiac resynchronization therapy in milder LV dysfunction and after right ventricular pacing were shown.
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved